Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice.
J Am Heart Assoc
; 10(8): e019467, 2021 04 20.
Article
en En
| MEDLINE
| ID: mdl-33834845
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Síndrome Coronario Agudo
/
Clopidogrel
/
Ticagrelor
/
Hemorragia
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
Europa
Idioma:
En
Revista:
J Am Heart Assoc
Año:
2021
Tipo del documento:
Article